PURPOSE: To assess the efficacy of amniotic membrane transplantation for the improvement of symptoms in bullous keratopathy. MATERIAL AND METHOD: Prospective study. 14 patients were operated between 01.02.2003 - 01.02.2006. the follow-up period: between 6 and 42 months with an average of 18 months. The following parameters were evaluated: corneal re-epithelialisation appearance of epithelial bullae, pain, photophobia. RESULTS: In 11 cases there was an improvement of the symptomatology: complete in 8 cases and partial in 3 cases. CONCLUSIONS: Amniotic membrane transplantation is an efficient palliative treatment for bullous keratopathy.
PURPOSE: To assess the efficacy of amniotic membrane transplantation for the improvement of symptoms in bullous keratopathy. MATERIAL AND METHOD: Prospective study. 14 patients were operated between 01.02.2003 - 01.02.2006. the follow-up period: between 6 and 42 months with an average of 18 months. The following parameters were evaluated: corneal re-epithelialisation appearance of epithelial bullae, pain, photophobia. RESULTS: In 11 cases there was an improvement of the symptomatology: complete in 8 cases and partial in 3 cases. CONCLUSIONS: Amniotic membrane transplantation is an efficient palliative treatment for bullous keratopathy.
Authors: Courtney A McDonald; Natalie L Payne; Guizhi Sun; Leon Moussa; Christopher Siatskas; Rebecca Lim; Euan M Wallace; Graham Jenkin; Claude C A Bernard Journal: J Neuroinflammation Date: 2015-06-03 Impact factor: 8.322